pulmotect.com

Pulmotect, Inc. |

BOOSTING THE INNATE IMMUNE SYSTEM. Even with modern advances in vaccines and antibiotics. There are significant unmet needs:. Forecast sales for the immuno-stimulants market are estimated to reach $17.6 billion. The Cancer Market Outlook to 2013:. Competitive landscape, pipeline analysis. More than 2 billion people worldwide. Could be impacted by a pandemic. 160 million Americans. Will need to be vaccinated. CDC Declares 2015 Flu Epidemic. Allergy and Infectious Disease.

http://www.pulmotect.com/

OVERVIEW OF pulmotect.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

5

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR PULMOTECT.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 1.0 out of 5 with 1 reviews

5 star

0

4 star

0

3 star

0

2 star

0

1 star

1

Hey there! Start your review of pulmotect.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.2 seconds

CONTACTS AT PULMOTECT.COM

Pulmotect

Brenton Scott

3900 Es●●●●●●●ne #250

Ho●●on , Texas, 77027

United States

713●●●226

bs●●●●@pulmotect.com

View this contact

Pulmotect

Brenton Scott

3900 Es●●●●●●●ne #250

Ho●●on , Texas, 77027

United States

713●●●226

bs●●●●@pulmotect.com

View this contact

Pulmotect

Brenton Scott

3900 Es●●●●●●●ne #250

Ho●●on , Texas, 77027

United States

713●●●226

bs●●●●@pulmotect.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2006 November 15
UPDATED: 2013 September 16
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

18

YEARS
6

MONTHS
25

DAYS

NAME SERVERS

1: dns1.stabletransit.com
2: dns2.stabletransit.com

REGISTRAR

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

PAGES IN
THIS WEBSITE

5

SSL

EXTERNAL LINKS

3

SITE IP

209.59.160.36

LOAD TIME

1.188 sec

SCORE

6.2

PAGE TITLE

Pulmotect, Inc. | | pulmotect.com Reviews

<META> DESCRIPTION

BOOSTING THE INNATE IMMUNE SYSTEM. Even with modern advances in vaccines and antibiotics. There are significant unmet needs:. Forecast sales for the immuno-stimulants market are estimated to reach $17.6 billion. The Cancer Market Outlook to 2013:. Competitive landscape, pipeline analysis. More than 2 billion people worldwide. Could be impacted by a pandemic. 160 million Americans. Will need to be vaccinated. CDC Declares 2015 Flu Epidemic. Allergy and Infectious Disease.

<META> KEYWORDS

1 the company

2 about us

3 management team

4 the product

5 the market

6 in the news

7 select page

8 immunocompromised patients

9 and growth opportunities

10 epidemic

CONTENT

Page content here

KEYWORDS ON PAGE

the company,about us,management team,the product,the market,in the news,select page,immunocompromised patients,and growth opportunities,epidemic,time,emerging pathogens,worldwide,national institute of,facebook,twitter,google

SERVER

Apache/2.2.29 (Unix) mod_ssl/2.2.29 OpenSSL/1.0.1e-fips mod_bwlimited/1.4

POWERED BY

PHP/5.4.43

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Pulmotect, Inc. | | pulmotect.com Reviews

https://pulmotect.com

BOOSTING THE INNATE IMMUNE SYSTEM. Even with modern advances in vaccines and antibiotics. There are significant unmet needs:. Forecast sales for the immuno-stimulants market are estimated to reach $17.6 billion. The Cancer Market Outlook to 2013:. Competitive landscape, pipeline analysis. More than 2 billion people worldwide. Could be impacted by a pandemic. 160 million Americans. Will need to be vaccinated. CDC Declares 2015 Flu Epidemic. Allergy and Infectious Disease.

INTERNAL PAGES

pulmotect.com

1

| Pulmotect, Inc.

http://pulmotect.com/products

Remarkably, despite a surface area nearly the size of a tennis court, the lungs are typically capable of defending themselves against inhaled pathogens. However, during times of immunocompromise (cancer, transplant, elderly, etc.), an unusual pathogen (pandemic), or a particularly aggressive pathogen (bioterror attack) it would be beneficial to boost the innate immune system of the lungs to fight against an infection and prevent the spread of the disease. How does it work? The innate immune system is the...

2

The Market | Pulmotect, Inc.

http://pulmotect.com/the-market

In Billions of Dollars. Spent on prevention and treatment of infectious disease, US estimates). PULMOTECT’S NOVEL PROPRIETARY TECHNOLOGY. Provides access to an estimated $50-100 billion infectious disease market by addressing significant unmet needs in the prevention of pneumonia (a leading cause of death worldwide) and other respiratory infections in broad and diverse patient populations (e.g. oncology, ICU, transplant, AIDS/HIV, elderly, seasonal flu, pandemics, bioterror, and others).

3

In the News | Pulmotect, Inc.

http://pulmotect.com/company/in-the-news

Pulmotect Completes Second Clinical Trial, Closes $1.75M Investment, Earns $1M NIH Award. Pulmotect, Inc. is Awarded $3 Million NIH Grant to Fund Infection Prevention Drug Trials. Pulmotect Completes Clinical Testing, Receives CPRIT Funding for Continued Development. Pulmotect Wins Southeast BIO Early Stage Shootout. CPRIT Awards Pulmotect $7.1 Million to Develop Novel Immune Stimulant. Texas Emerging Technology Fund Makes Investment in Pulmotect. Lab Finds Fast Way to Boost Immunity.

4

Management Team | Pulmotect, Inc.

http://pulmotect.com/company/the-team

PULMOTECT’S MANAGEMENT TEAM includes the lead inventors of the technology. As well experienced business leaders. In collaboration with leading academic institutions,. This team is well positioned to achieve the milestones and transition our products through the clinic. Brenton Scott, PhD. President and co-founder of Pulmotect. Leo Linbeck, III. Chairman of the Board and CEO of Aquinas Companies, LLC,. Burton Dickey, MD. Dr Dickey is an inventor of the original platform technology and is a co-founder of P...

5

Company | Pulmotect, Inc.

http://pulmotect.com/company

Is a Houston-based clinical stage biotechnology company, developing products that boost the innate immune system to protect against a wide range of lung infections. Our cofounders are leaders in the emerging science of innate immunity in the lungs. Our technologies stimulate the body’s natural defenses to provide safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague).

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

5

LINKS TO THIS WEBSITE

techtransfer.tamu.edu

Technology Commercialization - Home Page

http://techtransfer.tamu.edu/NewVentures/Startups.shtml

Protect your IP Rights. Http:/ www.3scan.com. Kevin R. Weiss, PE, PLS, CEO and President. Http:/ www.byogy.com. Richard Smith, PhD., GISP, President. Http:/ www.CartoFusionTech.com. William Altman, President and CEO. Http:/ www.corinnova.com. Cyndi Nickel, CEO and President. Http:/ www.dxupclose.com. James Lancaster, CEO. Http:/ www.ecolyse.com. Jason Ornstein, CEO and Founder. Http:/ www.framergy.com. Freight Shuttle Development Corp. Robert Radovan, Chief Development Officer. LifeBot, a telemedicine so...

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

3

OTHER SITES

pulmoreview.blogspot.com

PULMO REVIEW ON-LINE

Saturday, April 09, 2005. This article has been published by the International Biopharmaceutical Association www.ibpassociation.org. Please note this article does not give any medical advice. The project is sponsored by Kriger Research - CRO and Training Services ( www.kriger.com. And ClinQua CRO ( www.clinqua.com. Start your Clinical Research Career Now. Clinical Research Associate Program. Marketing and Management Program. SAS Programming Trainig Program. Kriger Research Group International.

pulmorphix.com

Pulmorphix. An OIP Revolution

At the forefront of the revolution in orally inhaled products. We’ve developed what we believe is the world’s first ‘lung biosimulator’ a device that replicates the conditions deep in the human lung. Pulmorphix Ltd is a specialist Contract Research Organisation focused on the dissolution profiling and rational development of orally inhaled products (OIPs). We have designed the world’s first lung bio-simulator for the investigation of OIPs in a physical environment reflective of the lung.

pulmoscience.org

一応知っておく | 脂肪吸引の手術を受ければたった1日でダイエットが成功

pulmoscope.com

Welcome to Pulmoscope | Pulmoscope

Skip to main content. No front page content has been created yet.

pulmostent-project.com

News Area: Pulmostent

Skip to navigation (Press Enter). Skip to main content (Press Enter). The research leading to these results has received funding from the European Union's Seventh Framework Programme. FP7/2007-2013 under grant agreement n NMP3-SL-2012-280915 ). The information, documentation and figures available in these documents, do not necessarily reflect the views of the European Commission or the PulmoStent Project Consortium. PulmoStent is the cover story of the summer semester edition of the RWTH Themen. On April...

pulmotect.com

Pulmotect, Inc. |

BOOSTING THE INNATE IMMUNE SYSTEM. Even with modern advances in vaccines and antibiotics. There are significant unmet needs:. Forecast sales for the immuno-stimulants market are estimated to reach $17.6 billion. The Cancer Market Outlook to 2013:. Competitive landscape, pipeline analysis. More than 2 billion people worldwide. Could be impacted by a pandemic. 160 million Americans. Will need to be vaccinated. CDC Declares 2015 Flu Epidemic. Allergy and Infectious Disease.

pulmotek.com

Alan adı tescil ve alan adı sorgulama, domain kayıt, domain tescil ve domain sorgulama,alan adı alma, domain alma işlemleri.

DOMAIN PARK - pulmotek.com. Bu alan adı natro.com üzerinden park edilmiştir. This domain name has been parked over natro.com. 5000 MB Aylık Trafik. 500 MB Web alanı. Alan Adı Whois Sorgulama. Sertifikalar and Çözüm Ortakları. Yeni Alan Adı Kaydı. Toplu Alan adı Kaydı. Alan adı Kayıt Sözleşmesi.

pulmotor.com

Louisville SEO,Web Designers, Search Engines Optimization and Internet Marketing Company Kentucky

We help achieve business objectives. Get your business visible locally. We assure you that your information will not be shared with any third party. We Have The Best Solution For You! Dominate Your Local Competitors. Rank High in Search Engines. Increase numbers of Clients/Customers. Full Service Web Marketing. Google Ads Campaign Management. Louisville SEO and Web Marketing. Top Search Engine Ranking. And Search Engine Marketing.

pulmotrainer.com

Mucus Clearance Device - PulmotrainerPulmotrainer.com

PULMOTRAINER -Mucus Clearance Device. TAKE IT EASY, BREATHE IN EASY. 8220;TAKE IT EASY, BREATHE IN EASY. Pulmonary function improver device for asthmatic and respiratory problems Postoperative use lung training to increase vital capacity and lung function, avoiding postoperative complication (for example postoperative inflammation). You can set the position of the ball inside the PULMOTRAINER with the scale on the side depending on you current lung capacity. So both children and adults can use it!

pulmotrainer.hu

Pulmotrainer

PULMOTRAINER - Légzésjavító készülék. ASZTMATIKUS ÉS LÉGÚTI-LÉGZŐSZERVI PANASZOK. Vényre kapható, OEP által finanszírozott, TB támogatás: 80% vagy Közgyógy 100%. 8220;PULMOTRAINER A TÜDŐ EDZŐJE”. Asztmatikus és légúti panaszok kezelésére kifejlesztett pipa formájú készülék. Ezt a pipát nem szívni, hanem fújni kell! A pipában lévő golyó a fújáskor rezgésbe jön, ezt átveszi a tüdő és az orrüreg. A pipa mechanikus rezgése felszítja az ott letapadt váladékot, melyet könnyen ki lehet fújni, vagy felköhögni.

pulmotrainer.pl

Pulmotrainer | Oddychaj lekko i swobodnie

Brak produktów w koszyku. Suma: 0.00 zł. Pulmotrainer Oddychaj lekko i swobodnie. Pulmotrainer to innowacyjne urządzenie typu flutter, które umożliwia korzystanie z pozytywnych efektów dodatniego ciśnienia wydechowego oraz wibracyjnego masażu dróg oddechowych. Pulmotrainer, flutter, natlenianie płuc, POChP, astma oskrzelowa, zapalenie oskrzeli, przewlekły kaszel, kaszel z wydzieliną, rozedma płuc, rozstrzenie oskrzeli, mukowiscydoza, pierwotna dyskineza rzęsek. Poprawia pracę płuc i ich natlenienie,.